ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Okay New Program Project Grants In Prevention

January 27, 1995

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990